| Your Resource for Neurotherapeutics Discovery and Development |
- Home
- Annual Meeting
Annual Meeting OverviewJoin us as the American Society for Experimental Neurotherapeutics Annual Meeting (ASENT 2027) will be held at Hyatt Regency Bethesda, in Bethesda, MD from March 17-19, 2027. Neurotherapeutics Clinical Trials Course: March 15-16, 2027 ASENT's 2027 Annual Meeting is the premier neuroscience and neurotherapeutics conference where senior leaders from healthcare payers, providers and prescribers, employers, investors, fast-growing startups, big pharma, policymakers, funders and innovation centers gather to improve the process of bringing neurotherapeutics to market. The ASENT 2027 Annual Meeting features 9 sessions which address therapeutic challenges and opportunities across a broad range neurologic diseases, addressing contemporary preclinical, clinical and regulatory issues that affect the development of new therapies. The meeting also features interactive poster presentations, oral abstract presentations, and live discussion with speakers at the end of each day. 2027 Meeting Highlights
Meeting LocationHyatt Regency Bethesda, Bethesda MDWho Attends30% Academia / 30% Industry / 30% Government / 10% Advocacy 50% of attendees are practicing physicians Physician-Scientists | Neurologists | Neuroscientists | Drug and Device Companies | Fellows | Post-docs | Founders | Funders | Industry Leaders | Nonprofit Organizations and Advocacy Groups | Journal Editors | Representatives from NIH, NIA, NIDA, NINDS and FDA We encourage early career scientists and clinicians to attend both the clinical trials course and the annual meeting. Trainees interested in neurotherapeutics development receive the opportunity to network with established investigators and leaders in industry and academia, including practicing clinicians conducting clinical research. |
Experimental Neurotherapeutics |
